Integrated Filing — IndAS



General information about company

Scrip Code 544595
NSE Symbol ORKLAINDIA
MSEI Symbol NOTLISTED
ISIN INE16NZ01023
Name of company ORKLA INDIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Food products and beverages
Start date and time of board meeting 13-11-2025   15:00:00
End date and time of board meeting 13-11-2025   15:40:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 18-09-2025
Indicate Company website link for updated RPT policy of the Company https://www.orklaindia.com/wp-content/uploads/sites/3/2025/09/Policy-on-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No Default



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 63,800.60 1,22,483.20
Other income 1,025.50 1,867.20
Total income 64,826.10 1,24,350.40
2 Expenses
(a) Cost of materials consumed 28,652.20 55,120.90
(b) Purchases of stock-in-trade 6,723.10 11,589.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (164.70) 165.10
(d) Employee benefit expense 6,113.90 12,195.10
(e) Finance costs 173.60 338.00
(f) Depreciation, depletion and amortisation expense 1,265.00 2,497.50
(f) Other Expenses
1 Consumption of stores and spares 166.40 328.50
2 Power and fuel 587.80 1,145.80
3 Processing & water charges 41.30 76.70
4 Repairs and maintenance 1,071.80 2,003.60
5 Rent 266.60 546.20
6 Provision for balances with government authorities 0.00 0.00
7 Rates and taxes 77.90 164.80
8 Insurance 137.50 233.70
9 Communication costs 19.00 43.90
10 Others 9,594.10 17,334.10
Total other expenses 11,962.40 21,877.30
Total expenses 54,725.50 1,03,782.90
3 Total profit before exceptional items and tax 10,100.60 20,567.50
4 Exceptional items 0.00 0.00
5 Total profit before tax 10,100.60 20,567.50
6 Tax expense
7 Current tax 2,407.10 4,801.00
8 Deferred tax 136.60 446.50
9 Total tax expenses 2,543.70 5,247.50
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 7,556.90 15,320.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 7,556.90 15,320.00
17 Other comprehensive income net of taxes 195.20 68.60
18 Total Comprehensive Income for the period 7,752.10 15,388.60
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,369.90 1,369.90
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.52 11.18
Diluted earnings (loss) per share from continuing operations 5.52 11.18
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.52 11.18
Diluted earnings (loss) per share from continuing and discontinued operations 5.52 11.18
24 Debt equity ratio 0.00 0.00
25 Debt service coverage ratio 0.00 0.00
26 Interest service coverage ratio 0.00 0.00
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. In terms of regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the aforesaid statement of unaudited standalone financial results of Orkla India Limited (formerly known as Orkla India Private Limited and MTR Foods Private Limited) [the Company] for the quarter and half year ended September 30, 2025 were reviewed by the Audit Committee at the meeting held on November 12, 2025 and approved by the Board of Directors at the meeting held on November 13, 2025. 2. The above unaudited standalone financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard specified under Section 133 of the Companies Act, 2013, as amended, read with Companies (Indian Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), as amended (“Listing Regulations”). 3. The figures for the six months ended September 30, 2025 are aggregate of quarter ended June 30, 2025 which have been subjected to audit and quarter ended September 30, 2025 which have been subjected to limited review. 4. Subsequent to the quarter ended September 30, 2025, the Company has completed its Initial Public Offering (IPO) of 22,843,004 equity shares with a face value of Re. 1 each at an issue price of Rs. 730 per share (includes employee reservation portion of 30,000 equity shares with a face value of Re. 1 each at an issue price of Rs. 661 per share), consisting entirely of offer for sale of 22,843,004 shares. The total proceeds on account of offer for sale is Rs. 16,673.3 million. The Company's equity shares were listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on November 06, 2025. 5. Consequent to IPO of the Company as explained in note 4 above, the statement of unaudited standalone financial results for the quarter and six months ended September 30 2025, is drawn up for the first time in accordance with the requirement of Regulation 33 of the Listing Regulations, which have been reviewed by the Audit Committee at the meeting held on November 12, 2025 and approved by the Board of Directors at the meeting held on November 13, 2025. The statutory auditors of the Company have conducted a limited review of the above unaudited standalone financial results. Further, the figures for the quarter and six months ended September 30, 2024 as reported in these unaudited standalone financial results have been approved by the Board of Directors but have not been subjected to review of the statutory auditors. 6. (i) Pursuant to a fire incident at Theni manufacturing plant, ECPL had filed a claim with the insurance company for the losses incurred on account of the damages. Further, ECPL recognised a minimum insurance claim receivable of Rs. 203.2 million in prior years. Based on the terms of the SPA, the Promoters of ECPL (Promoters) had agreed to compensate the Company for the claim receivable from the insurance company, in case the same is not received from the insurance company by December 2024. As per the Settlement Agreement dated March 8, 2025, the Promoters has paid the aforesaid claim to the Company. Accordingly, the Company has written off the insurance claim receivable from the insurance company and recorded a corresponding income against the claim received from the Promoters during the year ended March 31, 2025. (ii) As at the time of acquisition in March 2021, the Company had adjusted the purchase consideration for certain existing and potential litigations/claims as deemed appropriate. Based on the terms of the SPA, the Company is liable to refund the adjusted amounts to the Promoters in case they receive favourable orders against such litigations within a specified timeline. During the year ended March 31, 2025, the Company: (a) received favourable orders in certain tax matters and accordingly paid the net adjusted amount of Rs. 121.7 million to the Promoters (b) reassessed the open tax litigation matters and based on the merits of the case, provision of Rs. 235.0 million has been created as payable to Promoters 7. Based on the guiding principles given in 'Ind AS 108 - Operating Segments', the Company's business activity falls within a single operating segment, namely Food products and beverages. Accordingly, no separate segment information has been provided. 8. The above unaudited standalone financial results of the Company are available on the Company's website (www.orklaindia.com) and also on the website of BSE (www.bseindia.com) and NSE (www.nseindia.com) where the shares of the Company are listed.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 39,043.60
Capital work-in-progress 562.50
Investment property 0.00
Goodwill 1,01,154.60
Other intangible assets 57,977.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 2,873.40
Trade receivables, non-current 0.00
Loans, non-current 61.10
Other non-current financial assets 788.10
Total non-current financial assets 3,722.60
Deferred tax assets (net) 0.00
Other non-current assets 12,294.20
Total non-current assets 2,14,754.50
2 Current assets
Inventories 29,754.80
Current financial asset
Current investments 32,411.70
Trade receivables, current 18,194.50
Cash and cash equivalents 1,095.90
Bank balance other than cash and cash equivalents 0.20
Loans, current 241.20
Other current financial assets 8,587.40
Total current financial assets 60,530.90
Current tax assets (net) 0.00
Other current assets 9,436.40
Total current assets 99,722.10
3 Non-current assets classified as held for sale 2,906.40
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 3,17,383.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,369.90
Other equity 2,59,745.10
Total equity attributable to owners of parent 2,61,115.00
Non controlling interest
Total equity 2,61,115.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 6,385.00
Total non-current financial liabilities 6,385.00
Provisions, non-current 0.00
Deferred tax liabilities (net) 10,773.00
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 17,158.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 3,834.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 18,755.00
Total Trade payable 22,589.00
Other current financial liabilities 11,633.00
Total current financial liabilities 34,222.00
Other current liabilities 1,912.00
Provisions, current 2,976.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 39,110.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 56,268.00
Total equity and liabilites 3,17,383.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) 1. In terms of regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the aforesaid statement of unaudited standalone financial results of Orkla India Limited (formerly known as Orkla India Private Limited and MTR Foods Private Limited) [the Company] for the quarter and half year ended September 30, 2025 were reviewed by the Audit Committee at the meeting held on November 12, 2025 and approved by the Board of Directors at the meeting held on November 13, 2025. 2. The above unaudited standalone financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard specified under Section 133 of the Companies Act, 2013, as amended, read with Companies (Indian Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR'), as amended (“Listing Regulations”). 3. The figures for the six months ended September 30, 2025 are aggregate of quarter ended June 30, 2025 which have been subjected to audit and quarter ended September 30, 2025 which have been subjected to limited review. 4. Subsequent to the quarter ended September 30, 2025, the Company has completed its Initial Public Offering (IPO) of 22,843,004 equity shares with a face value of Re. 1 each at an issue price of Rs. 730 per share (includes employee reservation portion of 30,000 equity shares with a face value of Re. 1 each at an issue price of Rs. 661 per share), consisting entirely of offer for sale of 22,843,004 shares. The total proceeds on account of offer for sale is Rs. 16,673.3 million. The Company's equity shares were listed on the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on November 06, 2025. 5. Consequent to IPO of the Company as explained in note 4 above, the statement of unaudited standalone financial results for the quarter and six months ended September 30 2025, is drawn up for the first time in accordance with the requirement of Regulation 33 of the Listing Regulations, which have been reviewed by the Audit Committee at the meeting held on November 12, 2025 and approved by the Board of Directors at the meeting held on November 13, 2025. The statutory auditors of the Company have conducted a limited review of the above unaudited standalone financial results. Further, the figures for the quarter and six months ended September 30, 2024 as reported in these unaudited standalone financial results have been approved by the Board of Directors but have not been subjected to review of the statutory auditors. 6. (i) Pursuant to a fire incident at Theni manufacturing plant, ECPL had filed a claim with the insurance company for the losses incurred on account of the damages. Further, ECPL recognised a minimum insurance claim receivable of Rs. 203.2 million in prior years. Based on the terms of the SPA, the Promoters of ECPL (Promoters) had agreed to compensate the Company for the claim receivable from the insurance company, in case the same is not received from the insurance company by December 2024. As per the Settlement Agreement dated March 8, 2025, the Promoters has paid the aforesaid claim to the Company. Accordingly, the Company has written off the insurance claim receivable from the insurance company and recorded a corresponding income against the claim received from the Promoters during the year ended March 31, 2025. (ii) As at the time of acquisition in March 2021, the Company had adjusted the purchase consideration for certain existing and potential litigations/claims as deemed appropriate. Based on the terms of the SPA, the Company is liable to refund the adjusted amounts to the Promoters in case they receive favourable orders against such litigations within a specified timeline. During the year ended March 31, 2025, the Company: (a) received favourable orders in certain tax matters and accordingly paid the net adjusted amount of Rs. 121.7 million to the Promoters (b) reassessed the open tax litigation matters and based on the merits of the case, provision of Rs. 235.0 million has been created as payable to Promoters 7. Based on the guiding principles given in 'Ind AS 108 - Operating Segments', the Company's business activity falls within a single operating segment, namely Food products and beverages. Accordingly, no separate segment information has been provided. 8. The above unaudited standalone financial results of the Company are available on the Company's website (www.orklaindia.com) and also on the website of BSE (www.bseindia.com) and NSE (www.nseindia.com) where the shares of the Company are listed.



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/(losses) on defined benefit plans 26050000 9030000
Total Amount of items that will not be reclassified to profit and loss 260.50 90.30
2 Income tax relating to items that will not be reclassified to profit or loss 65.30 21.70
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 195.20 68.60



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 20,567.50
Adjustments for reconcile profit (loss)
Adjustments for finance costs 289.00
Adjustments for decrease (increase) in inventories 764.30
Adjustments for decrease (increase) in trade receivables, current (2,069.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (2,904.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (3,741.50)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 2,497.10
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 128.00
Adjustments for provisions, current 299.20
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (12,002.00)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (345.00)
Adjustments for dividend income 0.00
Adjustments for interest income 400.00
Adjustments for share-based payments 17.00
Adjustments for fair value losses (gains) (98.40)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (250.30)
Other adjustments to reconcile profit (loss) (9.40)
Other adjustments for non-cash items 21.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (17,804.00)
Net cash flows from (used in) operations 2,763.50
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 4,828.40
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (2,064.90)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,017.80
Proceeds from sales of investment property 27.90
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 12,999.40
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 1,027.20
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (16,975.40)
Net cash flows from (used in) investing activities (3,938.70)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 348.00
Dividends paid 0.00
Interest paid 289.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (637.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (6,640.60)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (6,640.60)
Cash and cash equivalents cash flow statement at beginning of period 7,736.60
Cash and cash equivalents cash flow statement at end of period 1,096.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Orkla India Limited Orkla ASA Ultimate holding company Purchase of goods or services 176.00 No remarks by Audit Committee 33.90 5.00 15.50
2 Orkla India Limited Orkla Procurement AS Subsidiaries of Holding company Purchase of goods or services 148.80 No remarks by Audit Committee 78.70 11.30 13.00
3 Orkla India Limited Orkla Financial Services AS Subsidiaries of Holding company Purchase of goods or services 27.00 No remarks by Audit Committee 8.60 1.10 1.50
4 Orkla India Limited Orkla IMEA Trading LLC Subsidiaries of Holding company Purchase of goods or services 7,489.60 No remarks by Audit Committee 1,383.30 276.50 455.50 Textual Information(1)
5 Orkla India Limited Orkla ASA Ultimate holding company Any other transaction Reimbursement of expenses to related parties 48.00 Omnibus Approval by Board of Directors 16.80 0.00 4.70
6 Orkla India Limited Orkla IT AS Subsidiaries of Holding company Any other transaction Reimbursement of expenses to related parties 96.00 Omnibus Approval by Board of Directors 31.60 0.00 0.00
7 Orkla India Limited Eastern Condiments Middle East & North Africa FZC, UAE Joint venture Any other transaction Reimbursement of expenses to related parties 4,800.00 Approved by Audit Committee and Board of Directors 1,101.70 10.90 13.30 Textual Information(2)
8 Orkla India Limited Orkla ASA Ultimate holding company Any other transaction Reimbursement of expenses from related parties 62.40 Omnibus Approval by Board of Directors 1.20 0.00 0.20
9 Orkla India Limited Orkla IT AS Subsidiaries of Holding company Any other transaction Reimbursement of expenses from related parties 10.00 No remarks by Audit Committee 1.20 0.00 0.20
10 Orkla India Limited Orkla Procurement AS Subsidiaries of Holding company Any other transaction Reimbursement of expenses from related parties 10.00 No remarks by Audit Committee 1.20 0.00 0.20
11 Orkla India Limited Orkla ASA Ultimate holding company Any other transaction Share based payments 0.00 No remarks by Audit Committee 7.50 0.00 0.00
12 Orkla India Limited Pot Ful India Private Limited Associate Sale of goods or services 3.20 Omnibus Approval by Board of Directors 1.10 0.00 0.10
13 Orkla India Limited Mr. Sanjay Sharma Managing Director and Chief Executive Officer Remuneration No remarks by Audit Committee 441.70 0.00 0.00
14 Orkla India Limited Ms. Suniana Calapa Chief Financial Officer Remuneration No remarks by Audit Committee 135.00 0.00 0.00
15 Orkla India Limited Mr. Kaushik Seshadri Company secretary Remuneration No remarks by Audit Committee 16.80 0.00 0.00
16 Orkla India Limited Mr. Amit Jain Independent director Any other transaction Sitting Fees & Commission No remarks by Audit Committee 10.00 0.00 0.00
17 Orkla India Limited Ms. Meena Ganesh Independent director Any other transaction Sitting Fees & Commission No remarks by Audit Committee 9.00 0.00 0.00
18 Orkla India Limited Ms. Rashmi Satish Joshi Independent director Any other transaction Sitting Fees & Commission No remarks by Audit Committee 12.00 0.00 0.00
19 Orkla India Limited Mr. Shantanu Maharaj Khosla Independent director Any other transaction Sitting Fees & Commission No remarks by Audit Committee 12.00 0.00 0.00
Total value of transaction during the reporting period 3,303.30



Text Block

Textual Information(1) PAN not applicable
Textual Information(2) PAN not applicable